CUSIP: M68830104
What is CUSIP M68830104?
CUSIP M68830104 identifies MDWD - MediWound Ltd. - Common Shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP M68830104:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| HOLD Alapkezelo Zrt. | 8.1% | +23% | 1,039,954 | +48% | HOLD Alapkezelo Zrt. | 13 Feb 2026 | ||
| Rosalind Advisors, Inc. | 7% | 0% | 912,319 | 0% | Rosalind Advisors, Inc. | 31 Dec 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q1 | 0 | $0 | -$479,633 | 0 | |
| 2022 Q4 | 36,502 | $479,633 | -$14,904,707 | $13.14 | 1 |
| 2022 Q3 | 8,732,355 | $12,156,900 | +$7,886,736 | $1.39 | 26 |
| 2022 Q2 | 3,060,032 | $5,626,400 | +$494,287 | $1.84 | 19 |
| 2022 Q1 | 2,787,010 | $5,545,527 | -$1,735,379 | $1.99 | 24 |
| 2021 Q4 | 3,655,370 | $8,631,369 | +$258,584 | $2.36 | 27 |
| 2021 Q3 | 3,537,329 | $11,810,598 | -$1,010,498 | $3.34 | 25 |
| 2021 Q2 | 3,555,747 | $13,617,000 | -$5,837,199 | $3.83 | 23 |
| 2021 Q1 | 4,874,780 | $26,170,480 | +$652,531 | $5.37 | 27 |
| 2020 Q4 | 4,815,044 | $17,807,000 | +$769,998 | $3.70 | 26 |
| 2020 Q3 | 4,603,789 | $17,306,000 | +$273,265 | $3.76 | 25 |
| 2020 Q2 | 4,541,601 | $13,490,000 | -$4,902,499 | $2.97 | 23 |
| 2020 Q1 | 6,214,039 | $9,756,000 | -$982,416 | $1.57 | 20 |
| 2019 Q4 | 6,818,630 | $21,136,000 | -$831,538 | $3.10 | 23 |
| 2019 Q3 | 7,081,529 | $22,565,000 | -$2,317,194 | $3.20 | 19 |
| 2019 Q2 | 7,812,066 | $26,428,000 | -$2,051,734 | $3.38 | 24 |
| 2019 Q1 | 8,362,314 | $41,812,000 | +$1,415,133 | $5.00 | 24 |
| 2018 Q4 | 8,111,968 | $32,932,000 | -$2,741,335 | $4.06 | 21 |
| 2018 Q3 | 8,629,094 | $53,199,185 | -$1,620,579 | $6.15 | 24 |
| 2018 Q2 | 8,809,937 | $60,570,207 | +$176,379 | $6.90 | 19 |
| 2018 Q1 | 8,857,162 | $46,061,156 | -$153,501 | $5.20 | 19 |
| 2017 Q4 | 8,889,781 | $39,561,000 | +$1,410,544 | $4.45 | 22 |
| 2017 Q3 | 7,965,343 | $42,498,000 | +$14,965,316 | $5.34 | 19 |
| 2017 Q2 | 5,152,069 | $35,034,000 | -$4,705,694 | $6.80 | 19 |
| 2017 Q1 | 5,854,412 | $38,639,000 | -$638,538 | $6.60 | 17 |
| 2016 Q4 | 6,004,784 | $27,430,785 | -$231,066 | $4.58 | 20 |
| 2016 Q3 | 5,964,342 | $45,921,090 | -$21,022 | $7.70 | 21 |
| 2016 Q2 | 5,785,106 | $45,516,413 | +$22,619,146 | $7.89 | 18 |
| 2016 Q1 | 2,910,868 | $23,489,719 | +$44,635 | $8.07 | 16 |
| 2015 Q4 | 2,903,686 | $24,799,518 | +$200,667 | $8.54 | 18 |
| 2015 Q3 | 2,879,689 | $21,970,890 | +$2,483,340 | $7.63 | 17 |
| 2015 Q2 | 2,555,675 | $18,069,199 | -$1,434,477 | $7.07 | 17 |
| 2015 Q1 | 2,756,482 | $20,149,213 | +$803,653 | $7.24 | 15 |
| 2014 Q4 | 2,650,826 | $17,959,117 | -$3,313,445 | $6.66 | 16 |
| 2014 Q3 | 3,142,395 | $19,716,000 | -$4,131,129 | $6.29 | 21 |
| 2014 Q2 | 3,581,061 | $40,741,000 | +$34,275,141 | $11.38 | 21 |
| 2014 Q1 | 568,214 | $8,188,000 | +$8,188,000 | $14.41 | 1 |